05/08/2026
Barts Health's Dr Manish Saxena has described a new twice-yearly injection being trialled to help manage high blood pressure as a "game changer" if successful.
Barts Health NHS Trust is the first site in Europe to recruit into the Zenith Phase 3 trial, testing zilebesiran, a treatment to potentially help the 1 in 3 adults in the UK affected by high blood pressure and lower their risk of heart attacks and strokes.
The trial aims to recruit more than 11,000 people worldwide. Read more through the link in the comments 👇